BioLife Solutions Inc (BLFS)

Return on equity (ROE)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	-66,427	-139,805	-8,908	1,983	-1,657
Total stockholders’ equity	US$ in thousands	337,663	364,188	478,047	204,429	43,321
ROE		-19.67%	-38.39%	-1.86%	0.97%	-3.82%

December 31, 2023 calculation

ROE = Net income ÷ Total stockholders’ equity
= $-66,427K ÷ $337,663K
= -19.67%

The return on equity (ROE) for BioLife Solutions Inc has fluctuated over the past five years. In 2023, the ROE was -19.67%, deteriorating significantly from the -1.86% in 2021 and -3.82% in 2019. The company experienced a steep decline in 2022 with a ROE of -38.39%. The positive ROE of 0.97% in 2020 was a brief improvement before the subsequent downward trend. Overall, BioLife Solutions Inc has struggled to generate satisfactory returns for its shareholders, with negative ROE figures in recent years indicating challenges in efficiently utilizing shareholder equity to generate profits.